Author

Cody Fell

Rice UniversityORCID 0000-0002-1509-5116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1 Research Focus:phylogenetics / evolution· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Anthony E. DavisiD· 2 shared Jonathon DeBonisiD· 2 shared Michael R. DiehliD· 2 shared Oleg A. IgoshiniD· 2 shared Omid Veiseh AiD· 2 shared Zeshi WangiD· 2 shared Amir ArdeshiriD· 1 shared Chancellor SmithiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Anthony E. DavisORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodies

Cody Fell, Anthony E. Davis, Shalini Pandey, Michael Tyler Guinn, Zeshi Wang, Jonathon DeBonis, Chancellor Smith, Nathan Brown, Danna Murungi, 김연주, Imaan Mohandessi, Patrick Bednarz, Amir Ardeshir, Erin Haupt, Samuel Cuevas, , Omid Veiseh A

This paper develops a cell-based therapy that enables sustained, dose-tunable delivery of monoclonal antibodies through a single administration, demonstrating long-term efficacy and safety in preclinical models.

Science Advances · Oct 2, 2026Peer-reviewedBioengineering

Factors Influencing Monoclonal Antibody Pharmacokinetics Across Varying Immune Perturbations

Jonathon DeBonis, Anthony E. Davis, Zeshi Wang, Cody Fell, Michael R. Diehl, Oleg A. Igoshin, Omid Veiseh A

This study evaluates the pharmacokinetics of a human mAb in different mouse strains to identify suitable models for preclinical testing.

bioRxiv · Apr 29, 2025Immunology

Simulating big mechanically-active culture systems (BigMACS) using paired biomechanics-histology FEA modelling to derive mechanobiology design relationships.

Sabrina Schoenborn, Maoqi Yuan, Cody Fell, Chuanhai Liu, David Frederick Fletcher, Selene Pirola, Hon Fai Chan, Maria Ann Woodruff, Zhiyong Li, Yi‐Chin Toh, Mark C. Allenby

This study introduces a biomechanics-histology FEA framework to simulate BigMACS and derive mechanobiology design relationships for controlling cell behavior and tissue patterning.

Biofabrication · Apr 16, 2025Peer-reviewedBioengineering